Transplant Outcomes in Beta-Thalassemia Major Patients Receiving Combined Granulocyte Colony-Stimulating Factor-Primed Bone Marrow and Cord Blood Graft Compared to Granulocyte Colony-Stimulating Factor-Primed Bone Marrow Alone. [electronic resource]
Producer: 20190610Description: 20-29 p. digitalISSN:- 1421-9662
- Adolescent
- Bone Marrow Cells -- cytology
- Cell Differentiation -- drug effects
- Child
- Child, Preschool
- Cytomegalovirus -- physiology
- Disease-Free Survival
- Fetal Blood -- cytology
- Graft vs Host Disease -- etiology
- Granulocyte Colony-Stimulating Factor -- pharmacology
- HLA Antigens -- immunology
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Hematopoietic Stem Cells -- cytology
- Humans
- Immunosuppressive Agents -- therapeutic use
- Infant
- Retrospective Studies
- Severity of Illness Index
- Virus Activation
- beta-Thalassemia -- mortality
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.